Download as pdf or txt
Download as pdf or txt
You are on page 1of 15

ISSN 0975 -8542

Journal of Global Pharma Technology


Available Online at www.jgpt.co.in

Research Paper

Sequencing of Proteus Toxic Agglutinin (Pta) Gene in Proteus


mirabilis and Cytotoxic Effect of Pta on Human Colon Cancer Cell
and Human Kidney Cell
Lamees A. Abdul-Lateef

University of Babylon, College of Medicine, Department of Microbiology, Iraq.

Abstract

Objective:- Study the sequencing of Pta gene and the cytotoxic effect of pta gene on SW480 and ACHN
cell line.
Material and method:- Detection of pta gene by using PCR technique, detection of mutation in the Pta
gene by used automated sequencing. Also the cytotoxic effect of Pta toxin on cell lines of SW480 and
ACHN cell were used in vitro.
Results:- The result was revealed that the Pta gene is present in 17 isolates (15 isolated from urine and 2
isolates from stool). Sequencing of Pta gene from isolates of Proteus mirablis reveals of 43 mutations in
five isolates and gives identity in percentage (92-95%) with standard strand in NCBI web site. However,
the cytotoxic effect of Pta on cells line of SW480 and ACHN were used in vitro was also investigated. The
result was shown that the effect of Pta toxin on SW480 lead to the proliferation of cell was significantly
elevated when Pta toxin at 12.5%, 25%, and 50% concentrations. The concentration 50% of Pta toxin a
significantly better effect on cell growth On the other hand, ACHN cell was gradually increase in
growth at concentrations (6.25%, 12.5%%, 25%, and 50%)

Keywords: Proteus toxic agglutinin gene, Sequencing, Human colon cancer cell line, Human kidney cell
line.

Introduction
Proteus mirabilis is the causative Cytotoxicity, but not auto-agglutination,
microorganism of urinary tract infection requires serine protease activity. Generally,
(UTI) in the complicated urinary tract, most secreted auto-transporters have cytotoxic
recurrently in patients with the indwelling properties while membrane-bound auto-
catheters or structural abnormalities of the transporters mediate aggregation or
urinary tract [1]. However, Proteus is one of adhesion. Proteus toxic agglutinin is more
the causative agent of gastroenteritis active at pH is alkaline, since the activity of
especially this organism considered normal the urease enzyme result in a local elevates
micro flora of intestine. It expresses various the pH of urine during infection. Certainly,
virulence factors which are included the transcription and protein levels of
adhesions, toxins, motility, enzymes, Proteus toxic agglutinin are elevated when
quorum-sensing and immune invasion [2]. Proteus mirabilis is cultured in alkaline
conditions [4].
Pta (Proteus toxic agglutinin), an auto-
transporter with subtilis in-like serine However, the mechanism of Pta cytotoxicity
protease activity, anchored at the surface of is unknown, intoxication of host cell with
bacterial. It is one of six putative auto- Pta result in membrane damage, actin
transporters encoded in the genome of depolymerisation, and final lysis [4].
Proteus mirabilis strain HI4320 [3]. Proteus
toxic agglutinin is the first characterized Pta is a bi-functional outer-membrane auto-
auto-transporter that remains membrane- transporter that mediates cell–cell
bound and exhibits both activities. accumulation and furthermore contains a
©2009-2017, JGPT. All Rights Reserved 112
Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

catalytically active α-domain equipped of samples, this include 16 isolates were isolated
lysing bladder and kidney cells [5]. from urine sample with UTI patients, and 4
isolates were isolated from stool from patients
The irregular adhesin–toxin was early complaining with diarrhea. All samples or
distinguished as an outer-membrane surface- individual were admitted to Al-Hilla surgical
expressed protein that is recognized by the teaching hospital in Al-Hilla city/ Iraq.
mouse immune system [6], and the loss of
Proteus toxic agglutinin results in a critical
Diagnosis of Bacteria
colonization imperfection in the kidneys and
bladder, and in addition lessened pathology All samples were obtained from patients with
[4]. UTI and diarrhea was cultured on blood agar
and MacConkey agar and the plates were
Inactivation of Proteus toxic agglutinin incubated at 37⁰ C overnight. Diagnosis of the
results in a greater diminishment in bacteria was carried out by biochemical
cytotoxicity. Proteus toxic agglutinin describe methods (oxidise test, catalyse test, swarming,
as cytotoxin with no bacterial homologues that unease test, and IMViC test) according to
works optimally in the alkalinized urinary Bergy,s Manual for Determinative
tract, a characteristic of urease-mediated urea Bacteriology [9].
hydrolysis during Proteus mirabilis infection
[7]. DNA Extraction
Proteus toxic agglutinin is a surface- DNA was extracted from bacterial isolate
associated, alkaline protease, calcium- according to the kit (Promega/ U.S.A.)
dependent that exhibits time-dose-dependent
cytotoxicity with cultured epithelial Molecular Detection of Pta Gene by PCR
cells. Proteus mirabilis cytotoxicity was (Polymerase Chain Reaction)
diminished in an isogenic Proteus toxic
agglutinin mutant in vitro, and the mutant Primer and PCR conditions were used to
strain was likewise outcompeted by the wild- detect gene of Pta are present in table (1).
type strain during co challenge in a mouse However, each 25μl of PCR consist of each
model of Proteus urinary tract [8]. upstream and downstream primer (2.5 μl ),
Materials and Methods free nuclease water (2.5 μl ), DNA extraction
in concentration 0.1μg/ml (5μl ), and master
Patients mix (12.5 μl). The polymerase chain reaction
A total of 100 samples only 20 isolates of amp icon was detected by gel electrophoresis
Proteus mirabilis were recovered from clinical on 1.5% agarose gels for 40 min at 70 V.

Table 1: Primer sequence and PCR condition


Gene Primer sequence PCR condition Product Reference
size (bp)
Pta F:5'- GTGGATAGCGCATTCCCGTA-3' 95 ⁰ C 5min 1x 187 This study
R:5'- CAAAAAGACTGGGGGCTTGC-3' 95 ⁰ C 30sec
59.3 ⁰ C 30sec 30x
72 ⁰ C 20sec
72 ⁰ C 5min 1x

Detection of Pta Gene by Automated This method was performed according to


Sequencing [10] with some modification which is
According to the results of PCR product, include the flow rate of 1.2 ml / min and
several DNA samples were subjected to detector (florescence) at
sequencing by Macro gene Company/ USA, excitation=340nm and emission=440nm
which give the identity of the genes and the column used was C18- ODS (25
comprised with the original genes in gene cm * 4.6 mm).
bank by blast program which is available at
the national centre biotechnology information The system was formulated as the
(NCBI) following: 5 min elution with 20 %
acetonitrile, followed by a 30 min
Purification of Pta by HPLC (High
gradient to 80 % acetonitrile.
Performance Liquid Chromatography)

©2009-2017, JGPT. All Rights Reserved 113


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

Cell-line the crystal violet staining solution was added


to the cells in the 96 well plate. These cells
The Sw480 is a model for human colon
were fixed and stained for 20 minutes at
cancers and ACHN is the model of for human
room temperature. Next plate was
kidney cell line. The two cells line was kindly
generously rinsed and allowed to dry
obtained and cultured at cancer research lab
overnight. The next day the dried and
/ medical college – University of Babylon.
stained cells were measured at an
absorbance of 570nm by micro plate reader
The viable cells number was determined by
[12].
using crystal violet assay before and after
using the toxin. The toxin (Pta) was cultured
96 well plates with SW480 and ACHN cell Results and Discussions
line separately with different volume of
Detection of Pta Gene by PCR
toxins. Then the 96 well plates was incubated
at 37Cº for 24 hours. We divided the plated Pta is a recently recognized as virulence
cells into six groups: group 1 as a control (not factor in Proteus mirabilis. The PCR
treated); group 2 (add 3.13 µl of toxin); group technique was used investigation of the pta
3 (add 6.25 µl of toxin); group 4 (add 12.5 µl gene through the use of pieces of DNA with a
of toxin); group 5 (add 25µl of toxin) and limited number of oil go nucleotide which act
group 6 (add 50µl of toxin). The final cells as primer specialized a virulence gene of
volume with toxin was 200µl. The plated cells Proteus mirabilis. The result of the current
were incubated at 37°C for 24 hours before study was shown that pta gene was present
counting [11]. in 15 isolates out 16 isolates at rate (93.75%)
from urine samples and 2 isolates out of 4
Crystal Violet Assay
isolates at rate (50%) from stool samples as
The cultured cells were washed with 100µl of shown in fig (1).
Phosphate buffer saline (PBS) and 200µL of

M 1 2 3 4 5 6 7 8 9 10 11 12

1500bp
1000bp
500bp
187bp
100bp

Fig. 1: Agarose gel electrophoresis of PCR product of Pta gene. M: DNA marker (100-1500bp);
Lane (1): Negative control; Lane (2): Positive control, Lanes (3-10) isolates obtained from
urine; Lanes (11, 12) isolates obtained from stool

The result of current study is identical with possible, especially when pathogen specific
result obtained by [7] who were found that factor (e.g. auto transporter)
the pta gene is present in almost isolates of
Sequencing of Pta Gene
Proteus mirabilis. [2] Were found the
expression of pta was distinguished in The results of gene sequence analysis pta
urinary isolates Proteus mirabilis negative was shown that there were 43 mutation in 5
pta gene had reduced pathology as well as, isolates of the gene pta as shown in fig (2)
defect in colonization of kidneys and bladder and table (2)
Proteus mirabilis may not be as homogeneous
as once thought as genetic variance is

©2009-2017, JGPT. All Rights Reserved 114


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

1-Isolate number (1)

2- Isolate number (2)

3- Isolate number (3)

4- Isolate number (4)

©2009-2017, JGPT. All Rights Reserved 115


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

5- Isolate number (5)

Fig. 2: Sequencing results of pta gene of Proteus mirabilis in five isolates

Table 2: Type of mutations in the pta gene sequence in Proteus mirabilis


No. of Wild Mutant Site Change in amino acid Type of Effect
isolates type type mutation
GCT GC- 2556502 Deletion T Deletion Frame shift
GCA GC- 2556511 Deletion A Deletion Frame shift

TGA TG- 2556514 Deletion A Deletion Frame shift

1 AAA AAG 2556517 Lysine/Lysine Substitution Silent

CGA CAA 2556571 Arginine/Glutamine Substitution Missense

CAC CTC 2556580 Histidine/Leucine Substitution Missense

TAG TAA 2556614 Stop Substitution Nonsense

CAT AAT 2556618 Histidine/Asparagine Substitution Missense

TGG GGG 2556623 Tryptophan/Glycine Substitution Missense

AGT TTT 2556638 Serine/Phenylalanine Substitution Missense


2556639
GCT GGC 2556501 Alanine/Glycine Substitution Missense
2556502
2
AAA AAG 2556517 Lysine/Lysine Substitution Silent

CGA CGT 2556520 Arginine/Arginine Substitution Silent

CGA CAA 2556571 Arginine/Glycine Substitution Missense

CAC CTC 2556580 Histidine/Leucine Substitution Missense

CAT AAT 255618 Histidine/Asparagine Substitution Missense

AGT TTT 255639 Serine/Phenylalanine Substitution Missense


255640
TTT ttAT 2556504/2556505 Insertion A Insertion Frame shift

3 AAA AAG 2556517 Lysine/Lysine Substitution Silent

CAG CGT 2556520 Arginine/Arginine Substitution Silent

GAG AAG 2556557 Aspartic acid/Lysine Substitution Missense

CGA CAA 2556571 Arginine/Glycine Substitution Missense

TAG TAA 2556614 Stop Substitution Missense

AGT ATT 2556640 Serine/Isoleucine Substitution Missense


TCA TCG 2556493 Serine/Serine Substitution Missense

CCT CTT 2556495 Proline/Leucine Substitution Missense

TTG TTGG 2556498/2556499 Insertion G Insertion Frame shift

4 GCT GTCT 2556500/2556501 Insertion T Insertion Frame shift

ACT -CA 2556505 Deletion A Deletion Frame shift


2556507 Isoleucine/Threonine Substitution Missense

©2009-2017, JGPT. All Rights Reserved 116


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

TGA TG- 2556513 Deletion A Deletion Frame shift

AAA AAG 2556516 Lysine/Lysine Substitution Silent

CGA CGT 2556519 Arginine/Arginine Substitution Silent

CGA CAA 2556571 Arginine/Glutamine Substitution Missense

TAG TAA 2556614 Stop Substitution Nonsense

CAT AAT 2556618 Histidine/Asparagine Substitution Missense


GCT GGC 25564501 Alanine/Glycine Substitution Missense
25564502
5
AAA AAG 25564516 Lysine/Lysine Substitution Silent

GAT GAC 25564522 Asparagine/Asparagine Substitution Silent

GAG AGAG 25564541/25564542 Insertion A Insertion Frame shift

AGT AAT 25564549 Serine/Asparagine Substitution Missense

TAG TAA 25564614 Stop Substitution Nonsense

GTC TTC 25564640 Alanine/Phenylalanine Substitution Missense

The result of DNA sequencing should Mutations affect the pta gene through the
examined to verify the nucleotide sequence creation of change in the organization of the
with other word strain (Proteus mirabilis gene. The result was shown that there is
strain HI4320). The test was used to verify 8(18.60%) frame shift mutations, this
by using National Centre of Biotechnology mutation lead to reading shift and to
Information- BLAST online, it was precise completely different type of translation
program and give the accurate result of originally, and then a big change in the
identity percentage with standard strain translated protein.
(Proteus mirabilis strain HI4320) and they
were ranged from (92-95%). However, 10(23.25%) silent mutations, this
type of mutation do not lead to a change in
The result of current study was shown there the sequence of amino acid in the protein and
is more than one mutation in each isolate, do not alter function of protein.
and this displays that the type and location
of mutations that were found could lead to a Besides, there is 21(48.83%) missense
difference in the effect of these mutations mutations, this type of mutation influence
and some of these mutations leading to the phenotype because they lead to
change in the genetic code and then change substitution of amino acids and thus in
in the amino acids at the translation. protein, amino acid can replace another
amino acid very similar of chemical
The amp icon products of the gene show characteristic, the protein is still work
nucleotide variation which demonstrated the naturally. There are also amino acid encode
polymorphism of this gene. The alignment by more than one code which could result in
between all isolates show that the little mutation but does not produce any change in
conservation of pta gene. However this the translation. Finally the result show
mutations in isolates which alter the function 4(9.30%) nonsense mutations, this kind of
of gene. mutation lead to change code of amino acid
stop codon and then get a reduced function of
Effect of Mutations
the protein as shown in table (3).

Table 3: Effect of the type and percentage of mutation in pta gene


Effect of mutation Number Percentage
Frame shift 8 18.60%
Silent 10 23.25%
Missense 21 48.83%
Nonsense 4 9.30%
Total 43 99.98%

©2009-2017, JGPT. All Rights Reserved 117


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

Effect of Pta Toxin on SW480 and toxin at 12.5%, 25%, and 50%
ACHN Cells concentrations with compared to control
group. The concentration 50% of Pta toxin a
The effect of Pta toxin on SW480 cell was
significantly better effect on cell growth as
investigated and the result was shown that
shown in Fig (3).
the proliferation of cell was significantly
elevated after 24 hours incubation with Pta

Fig. 3: Sw480 cell proliferation rate after incubation 24 hr. with different concentration of Pta
toxin

The result showed that there was a high colon cancer. On the other hand, viable
effect on cancer cell line SW 480 through ACHN cell was incubated with Pta toxin for
increasing of the concentration of Pta toxin 24hr., after incubation with the toxin the
and the effect was reduced in the minimum result was showed that gradually increase of
concentration. This toxin leads to increase cell at concentrations (6.25%, 12.5%%, 25%,
proliferation of cancer cell, so this toxin acts and 50%) compared with control group as
as carcinogenic. There is no previous study shown in Fig (4).
on the cytotoxic effect of pta toxin on human

Fig 4: ACHN cell proliferation rate after incubation 24hr. with different concentration of Pta
toxin

©2009-2017, JGPT. All Rights Reserved 118


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

However, this toxin leads to proliferation of the host cell due to the destruction of
cell and cause cytopathic effect. The membrane was followed by outflow and
cytotoxicity was seen after toxin addition as condensation of the cell cytoplasm, and
shown in Fig (5), change of the morphology of breakdown of the cell components.

A B
Figure 5: Purified Pta toxin interaction with cells line; A: SW480 cell, B: ACHN cell

Proteus toxic agglutinin is the cytotoxin that Moreover, Proteus toxic agglutinin hole the
has been implicated in damage of host. The host cell membrane, leading to outflow of the
functions associated with Proteus toxic cytosol, osmotic stress and de-polymerization
agglutinin was an essential in the persistence of act in filaments; the structural integrity of
of the microbes in the host. However, Proteus the cell is therefore compromised, resulting
mirabilis caused the cytopathic effects in in bladder and kidney damage [4], [2].
infected person have been a critical clinical
importance Proteus toxic agglutinin acts as auto-
agglutination of Proteus mirabilis in addition
Proteus toxic agglutinin is present in Proteus toxicity against kidney and bladder cells of
mirabilis that has agglutinin and cytotoxin human when cultured in vitro [17].
properties when tested in vitro using human
Conclusion
kidney and bladder epithelial cell lines,
verifying that auto-transporter proteins could The genome sequence gives a significant clue
be cytotoxins [4]. to understand the regulatory and metabolic
network that link chromosomal genes.
Proteus toxic agglutinin as essential However, the isolates have mutation in pta
virulence factor in the uropathogen Proteus gene that is having no role in the
mirabilis The bacteria have ability to cause pathogenesis. In this regard, I establish the
necrosis to invade tissue though the ability to role of Proteus toxic agglutinin in the
produce toxin as Pta toxin [13]. pathogenesis in Proteus mirabilis; also the
Proteus toxic agglutinin toxin is considered
Because Proteus toxic agglutinin is not only a the cytotoxic effect on normal and cancer cell
key cytotoxin in Proteus mirabilis but also a
Acknowledgement
surface exposed protein that is a critical for
establishing an infection in the host. P. I thankful to Department of Microbiology,
mirabilis produce Pta, which is cause damage college of medicine, University of Babylon ,
of tissue and dissemination to the kidneys, Iraq, for the facilities provided in the
initiating acute pyelonephritis [14], [15]. completion of the work, I also thankful Dr.
Hameed Najei for their cooperation.
Proteus toxic agglutinin promoted cell–cell
Ethical Approval
aggregation of the microbe and, when the Pta
is interaction with the host, evoked a Agreement from patients for sampling
cytopathic effect. These features have strong collection and carrying out this work is
implications for the pathogenesis of Proteus obtained from each patient.
mirabilis infection in the host [16].

©2009-2017, JGPT. All Rights Reserved 119


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

Proteus mirabilis Pta gene, toxic agglutinin, partial sequence, strain: LA1
GenBank: LC318372.1
LOCUS LC318372 164 bp DNA linear BCT 02-SEP-2017
DEFINITION Proteus mirabilis Pta gene, toxic agglutinin, partial sequence,
strain: LA1.
ACCESSION LC318372
VERSION LC318372.1
KEYWORDS .
SOURCE Proteus mirabilis
ORGANISM Proteus mirabilis
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Morganellaceae; Proteus.
REFERENCE 1
AUTHORS Lamees A.A.
TITLE Sequencing of Proteus toxic agglutinin (Pta) gene in Proteus
mirablis and cytotoxic effect of Pta on human colon cancer cell and
human kidney cell
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 164)
AUTHORS Lamees A.A.
TITLE Direct Submission
JOURNAL Submitted (28-AUG-2017) Contact:Lamees A.Abdul-LateeF Ministry of
Higher Education and Scientific Research/Babylon University
/College of Medicine, Microbiology; 40 street, Al-Hilla, Babil
0000, Iraq
FEATURES Location/Qualifiers
source 1..164
/organism="Proteus mirabilis"
/mol_type="genomic DNA"
/strain="LA1"
/isolation_source="urine of colon cancer patient 1"
/host="Homo sapiens"
/db_xref="taxon:584"
/country="Iraq"
/collection_date="2016-12-01"
/collected_by="Lamees A. Abdul-LateeF"
/PCR_primers="fwd_seq: gtggatagcgcattcccgta, rev_seq:
caaaaagactgggggcttgc"
gene <1..>164
/gene="Pta"
misc_feature <1..>164
/gene="Pta"
/note="coding region not determined;
toxic agglutinin"
ORIGIN
1 gtttcctttt tgggctttac tgcatgaaag cgtgatccac tcaactcttg atgtgagagc
61 agtgcaccag agtccatcac cccaacttta gctccttgac catgaaaacc cagagcataa
121 gcactagagg aattcatggc tgcaagcccc ctttcttttt ggaa

©2009-2017, JGPT. All Rights Reserved 120


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

//

Proteus mirabilis Pta gene, toxic agglutinin, partial sequence, strain: LA2
GenBank: LC318373.1
LOCUS LC318373 160 bp DNA linear BCT 02-SEP-2017
DEFINITION Proteus mirabilis Pta gene, toxic agglutinin, partial sequence,
strain: LA2.
ACCESSION LC318373
VERSION LC318373.1
KEYWORDS .
SOURCE Proteus mirabilis
ORGANISM Proteus mirabilis
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Morganellaceae; Proteus.
REFERENCE 1
AUTHORS Lamees A.A.
TITLE Sequencing of Proteus toxic agglutinin (Pta) gene in Proteus
mirablis and cytotoxic effect of Pta on human colon cancer cell
and human kidney cell
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 160)
AUTHORS Lamees A.A.
TITLE Direct Submission
JOURNAL Submitted (28-AUG-2017) Contact:Lamees A.Abdul-LateeF Ministry of
Higher Education and Scientific Research/Babylon University
/College of Medicine, Microbiology; 40 street, Al-Hilla, Babil
0000, Iraq
FEATURES Location/Qualifiers
source 1..160
/organism="Proteus mirabilis"
/mol_type="genomic DNA"
/strain="LA2"
/isolation_source="urine of colon cancer patient 2"
/host="Homo sapiens"
/db_xref="taxon:584"
/country="Iraq"
/collection_date="2016-12-01"
/collected_by="Lamees A. Abdul-LateeF"
/PCR_primers="fwd_seq: gtggatagcgcattcccgta, rev_seq:
caaaaagactgggggcttgc"
gene <1..>160
/gene="Pta"
misc_feature <1..>160
/gene="Pta"
/note="coding region not determined;
toxic agglutinin"
ORIGIN
1 gtaccctttt ggctttactg ctgaagcgtg atccactcaa ctcttgatgt gagagcagtg
61 caccagagtc catcacccca actttagctc cttgaccatg aaaacccaga gcataagcac

©2009-2017, JGPT. All Rights Reserved 121


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

121 taaaggaatt cagggctgca agcccccttt ctttttggaa


//

Proteus mirabilis Pta gene, toxic agglutinin, partial sequence, strain: LA3
GenBank: LC318374.1
LOCUS LC318374 166 bp DNA linear BCT 02-SEP-2017
DEFINITION Proteus mirabilis Pta gene, toxic agglutinin, partial sequence,
strain: LA3.
ACCESSION LC318374
VERSION LC318374.1
KEYWORDS .
SOURCE Proteus mirabilis
ORGANISM Proteus mirabilis
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Morganellaceae; Proteus.
REFERENCE 1
AUTHORS Lamees A.A.
TITLE Sequencing of Proteus toxic agglutinin (Pta) gene in Proteus
mirablis and cytotoxic effect of Pta on human colon cancer cell
and human kidney cell
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 166)
AUTHORS Lamees A.A.
TITLE Direct Submission
JOURNAL Submitted (28-AUG-2017) Contact:Lamees A.Abdul-LateeF Ministry of
Higher Education and Scientific Research/Babylon University
/College of Medicine, Microbiology; 40 street, Al-Hilla, Babil
0000, Iraq
FEATURES Location/Qualifiers
source 1..166
/organism="Proteus mirabilis"
/mol_type="genomic DNA"
/strain="LA3"
/isolation_source="urine of colon cancer patient 3"
/host="Homo sapiens"
/db_xref="taxon:584"
/country="Iraq"
/collection_date="2016-12-01"
/collected_by="Lamees A. Abdul-LateeF"
/PCR_primers="fwd_seq: gtggatagcgcattcccgta, rev_seq:
caaaaagactgggggcttgc"
gene <1..>166
/gene="Pta"
misc_feature <1..>166
/gene="Pta"
/note="coding region not determined;
toxic agglutinin"
ORIGIN

©2009-2017, JGPT. All Rights Reserved 122


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

1 atgtggcttt ttttttttat actgcatgaa agcgtgatcc actcaactct tgatgtgaga


61 gcagtgcacc aaagtccatc accccaactt tagcaccttg accatgaaaa cccagagcat
121 aagcactaaa ggcattcatg gctgcaagcc cccattcttt ttggaa
//

Proteus mirabilis Pta gene, toxic agglutinin, partial sequence, strain: LA4
GenBank: LC318375.1
LOCUS LC318375 163 bp DNA linear BCT 02-SEP-2017
DEFINITION Proteus mirabilis Pta gene, toxic agglutinin, partial sequence,
strain: LA4.
ACCESSION LC318375
VERSION LC318375.1
KEYWORDS .
SOURCE Proteus mirabilis
ORGANISM Proteus mirabilis
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Morganellaceae; Proteus.
REFERENCE 1
AUTHORS Lamees A.A.
TITLE Sequencing of Proteus toxic agglutinin (Pta) gene in Proteus
mirablis and cytotoxic effect of Pta on human colon cancer cell and
human kidney cell
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 163)
AUTHORS Lamees A.A.
TITLE Direct Submission
JOURNAL Submitted (28-AUG-2017) Contact:Lamees A.Abdul-LateeF Ministry of
Higher Education and Scientific Research/Babylon University
/College of Medicine, Microbiology; 40 street, Al-Hilla, Babil
0000, Iraq
FEATURES Location/Qualifiers
source 1..163
/organism="Proteus mirabilis"
/mol_type="genomic DNA"
/strain="LA4"
/isolation_source="urine of colon cancer patient 4"
/host="Homo sapiens"
/db_xref="taxon:584"
/country="Iraq"
/collection_date="2016-12-01"
/collected_by="Lamees A. Abdul-LateeF"
/PCR_primers="fwd_seq: gtggatagcgcattcccgta, rev_seq:
caaaaagactgggggcttgc"
gene <1..>163
/gene="Pta"
misc_feature <1..>163
/gene="Pta"
/note="coding region not determined;

©2009-2017, JGPT. All Rights Reserved 123


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

toxic agglutinin"
ORIGIN
1 agttcgcttt tgggtctttt cagcatgaag cgtgatccac tcaactcttg atgtgagagc
61 agtgcaccag agtccatcac cccaacttta gcaccttgac catgaaaacc cagagcataa
121 gcactaaagg aattcatggc tgcaagcccc cagtcttttt gga
//

Proteus mirabilis Pta gene, toxic agglutinin, partial sequence, strain: LA5
GenBank: LC318376.1
LOCUS LC318376 164 bp DNA linear BCT 02-SEP-2017
DEFINITION Proteus mirabilis Pta gene, toxic agglutinin, partial sequence,
strain: LA5.
ACCESSION LC318376
VERSION LC318376.1
KEYWORDS .
SOURCE Proteus mirabilis
ORGANISM Proteus mirabilis
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Morganellaceae; Proteus.
REFERENCE 1
AUTHORS Lamees A.A.
TITLE Sequencing of Proteus toxic agglutinin (Pta) gene in Proteus
mirablis and cytotoxic effect of Pta on human colon cancer cell and
human kidney cell
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 164)
AUTHORS Lamees A.A.
TITLE Direct Submission
JOURNAL Submitted (28-AUG-2017) Contact:Lamees A.Abdul-LateeF Ministry of
Higher Education and Scientific Research/Babylon University
/College of Medicine, Microbiology; 40 street, Al-Hilla, Babil
0000, Iraq
FEATURES Location/Qualifiers
source 1..164
/organism="Proteus mirabilis"
/mol_type="genomic DNA"
/strain="LA5"
/isolation_source="urine of colon cancer patient 5"
/host="Homo sapiens"
/db_xref="taxon:584"
/country="Iraq"
/collection_date="2016-12-01"
/collected_by="Lamees A. Abdul-LateeF"
/PCR_primers="fwd_seq: gtggatagcgcattcccgta, rev_seq:
caaaaagactgggggcttgc"
gene <1..>164
/gene="Pta"
misc_feature <1..>164

©2009-2017, JGPT. All Rights Reserved 124


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

/gene="Pta"
/note="coding region not determined;
toxic agglutinin"
ORIGIN
1 cccccttttt gggctttact gcatgaaagc gagacccact caactcttga tgtagagagc
61 aatgcaccag agtccatcac cccgacttta gcaccttgac catgaaaacc cagagcataa
121 gcactaaagg cattcatggc tgcaagcccc cattcttttt ggaa
//

References
1. Warren JW, Tenney JH, Hoopes JM, 7. Alamuri P, Eaton KA, Himpsl SD,
Muncie HL, Anthony WC (1982) A Smith SN, Mobley HLT (2009)
prospective microbiologic study of Vaccination with proteus toxic
bacteraemia in patients with chronic agglutinin, a haemolysin-independent
indwelling urethral catheters. J Infect cytotoxin in vivo, protects
Dis 146: 719-723. against Proteus mirabilis urinary tract
2. Armbruster CE, Mobley HL (2012) infection. Infect Immun,77:632–641
Merging mythology and morphology: 8. Chippendale GR., Warren JW, Trifillis,
the multifaceted lifestyle of Proteus AL, Mo- bley HLT (1994)
mirabilis. Nature Rev Microbial. Internalization of Proteus mirabilis by
10:743–754. human renal epithelial cells. Infection
and Immunity, 62, 3115-3121.
3. Pearson MM, Sebaihia M, Churcher C,
Quail MA, Seshasayee AS, Abdellah Z 9. Holt JC, Krieg NR, Sneath A, Stachley
(2008) The complete genome sequence JT, William ST (1994) Bergy,s manual
of uro pathogenic Proteus mirabilis, a of determinative bacteriology, 9thed.
master of both adherence and motility. USA, 552.
J Bacterial (in press). 10. Cock IE; van Vuurenc SF (2014) Anti-
4. Alamuri P, Mobley HL (2008) A novel Proteus Activity of South African
auto transporter of uro pathogenic Medicinal Plants: Their Potential for
Proteus mirabilis is both a cytotoxin the Prevention of Rheumatoid
and an agglutinin. Mol. Microbial, Arthritis. Inflammo pharmacology,
68:997–1017. 22(1), 23-36.
5. Flannery EL, Mody L, Mobley HLT 11. Kaiser NM, Rana AG, Firas MG,
(2009) Identification of a modular Zaineb HA (2015) The Effects of.
pathogen city island that is widespread Zizyphus Stem Bark and Termite
among urease-producing uropathogens Shelter Tubes on HeLa cell Growth.
and shares features with a diverse Research Journal of Pharmaceutical,
group of mobile elements. Infect Biological and Chemical Sciences.
Immun. 77:4887–4894. RJPBCS, 6(6):620.
6. Nielubowicz GR, Smith SN, Mobley 12. Zhenbo Xu, Yanrui Liang, Shiqi Lin,
HLT (2008) Outer membrane antigens Dingqiang Chen, Bing Li1, Lin Li1
of the uropathogen Proteus Yang Deng (2016) Crystal Violet and
mirabilis recognized by the humoral XTT Assays on Staphylococcus aureus
response during experimental murine Bio film Quantification .Curr
urinary tract infection. Infect Immun. Microbial, DOI 10.1007/s00284-016-
76:4222–4231. 1081-1.

©2009-2017, JGPT. All Rights Reserved 125


Lamees A. Abdul-Lateef : Journal of Global Pharma Technology. 2017; 09(9):112-126

13. Choubini E, Asadi Karam MR, 16. Stickler D, Ganderton L, King J,


Khorshidi A, Habibi M, Ghasemi A, Nettleton J, Winters C (1993) Proteus
Bouzari S (2016) Bioinformatics mirabilis bio films and the
analysis and expression of a truncated encrustation of urethral catheters.
form of Proteus mirabilis Pta protein Urol Res, 21: 407–411.
as a novel vaccine target against 17. Hutton JC (1990) Subtilisin-like
urinary tract infection. Vaccine proteinases involved in the activation
Research, 3(7), 30-35. of proportions of the eukaryotic
14. Jacobsen SM, Stickler DJ, Mobley HL, secretory pathway. Curr Opin Cell
Shortleaf ME (2008) Complicated Biol 2: 1131–1142
catheter-associated urinary tract
infections due to Escherichia
coli and Proteus mirabilis. Clin
Microbiol Rev, 21:26–59.
15. Cestari SE, Ludovico MS, Martins
FH, da Rocha SPD, Pelayo JS (2013)
Molecular detection of HpmA and
HlyA hemolysin of
uropathogenic Proteus mirabilis. Curr
Microbial. 67:703–707.

©2009-2017, JGPT. All Rights Reserved 126

You might also like